[Approaches to the development of the Japanese academic version of the MATRICS Consensus Cognitive Battery].
Cognitive impairment is related to functional outcome (e.g., work skills and community activities) in patients with schizophrenia; therefore, many researchers view these impairments as important treatment targets for psychopharmacological treatment. To stimulate the development of new treatments for cognitive impairments, the US National Institute of Mental Health's (NIMH's) Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) initiative developed a standard cognitive battery, i.e., the MATRICS Consensus Cognitive Battery (MCCB). In Japan, the MCCB has been initially translated as an academic version. This paper describes the process of developing the Japanese academic version and focuses on pilot studies on subtests of this battery.